title: Avastin in myopic choroidal neovascularisation: is age the limit?
authors.forename: David
authors.initials: D
authors.lastname: Wong
authors.forename: Kenneth K W
authors.initials: KK
authors.lastname: Li
mesh_terms: D000367:Age Factors; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D019317:Evidence-Based Medicine; D006801:Humans; D047728:Myopia, Degenerative / Q000150:complications*; D016032:Randomized Controlled Trials as Topic; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab